Broken Heart Syndrome vs. Heart Attack: Why the Type of Cardiogenic Shock Changes Everything

Cardiogenic shock is not a single disease. New national data led by Dr. Michael Megaly (senior author) show that when shock is caused by Takotsubo cardiomyopathy rather than a heart attack, the entire risk profile shifts, and so should the treatment strategy.

Cardiogenic shock remains one of the most lethal conditions in cardiovascular medicine. When the heart cannot pump enough blood to sustain the body's organs, mortality rates approach one in three even at experienced centers. Most shock protocols were built around the dominant cause: acute myocardial infarction, in which a blocked coronary artery kills heart muscle and collapses cardiac output.

But not all cardiogenic shock originates from a blocked artery. Takotsubo cardiomyopathy, often called broken heart syndrome or stress cardiomyopathy — produces sudden, severe left ventricular dysfunction without obstructive coronary disease. It can be just as hemodynamically devastating in the acute phase, yet the muscle is typically stunned rather than infarcted. Whether that distinction should change management has remained an open question.

Dr. Megaly served as senior author on a study published in the Canadian Journal of Cardiology examining this question at national scale. The investigators queried the Nationwide Readmissions Database from 2016 through 2022, identifying 236,831 cardiogenic shock hospitalizations. Of these, 7,942 were Takotsubo-related shock, and 228,889 were myocardial infarction–related shock.

The two populations differed substantially. Patients with Takotsubo-related shock were younger (median age 66 versus 69 years), overwhelmingly female (72.6% versus 34.6%), and carried fewer comorbidities.

The outcome data revealed a more complex picture than survival statistics alone suggest. Temporary mechanical circulatory support was used far less often in Takotsubo-related shock (12.8% versus 36.6%), and in-hospital mortality was lower (28.7% versus 35.4%). Yet these patients experienced significantly higher rates of stroke (7.8% versus 4.2%), major bleeding (24.3% versus 23.2%), and acute kidney injury requiring dialysis (9.7% versus 8.4%).

Within the Takotsubo-related shock cohort, multivariable analysis identified female sex, hypertension, and anemia as associated with higher survival, while older age, diabetes, end-stage renal disease, stroke, and cardiac arrest were associated with lower survival.

The clinical implication is that Takotsubo-related cardiogenic shock behaves as a distinct phenotype, potentially reversible, but complication-prone. Lower mortality does not mean lower acuity. The elevated stroke and bleeding rates argue for deliberate anticoagulation strategy, careful device selection, and neurologic vigilance rather than a simplified approach borrowed from infarct-related shock. For patients whose ventricle is stunned rather than infarcted, the goal is bridging to recovery, which changes the calculus around when and how mechanical support is deployed

Dr. Megaly, an interventional cardiologist at Integris Health Heart Hospital in Oklahoma City, focuses on complex and high-risk coronary intervention, including patients presenting in cardiogenic shock. The study reflects an ongoing research program examining how shock etiology should shape mechanical circulatory support decisions.

Zordok M, Al-Azizi K, Szerlip M, Basir MB, Alaswad K, Brilakis ES, Megaly M. Cardiogenic Shock in Takotsubo vs Acute Myocardial Infarction: Insights From the National Readmission Database 2016-2022. Canadian Journal of Cardiology. 2025;41(12):2431-2439.

Dr. Michael Megaly specializes in complex and high-risk coronary interventions, chronic total occlusion (CTO) PCI, surgical turn-downs, complex peripheral artery disease, and limb salvage at Integris Health Heart Hospital in Oklahoma City.